CD4 and glycogen storage disease VI: McHugh et al. used anti-CD4 antibody-conjugated biodegradable nanoparticles loaded with TGF-β and IL-2 to induce the expansion of CD4+ Treg cells in vitro to directly improve clinical therapies for inflammatory and cell-mediated diseases 118.